Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade

Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families

(2011) T. W. Wong et al.   CLINICAL CANCER RESEARCH

Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responsesin Vitroandin Vivo

(2011) Kevin C. Foy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In vivo fluorescence imaging of E-selectin: Quantitative detection of endothelial activation in a mouse model of arthritis

(2010) Luke L. Gompels et al.   ARTHRITIS AND RHEUMATISM

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

(2010) Roque Diaz et al.   BMC CANCER

The vasculature in rheumatoid arthritis: cause or consequence?

(2010) Ewa M. Paleolog   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry

(2009) F. Tubach et al.   ARTHRITIS AND RHEUMATISM

Cetuximab in the Treatment of Rheumatoid Arthritis

(2009) Timothy Sullivan et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-κB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis

(2009) Seong-Su Nah et al.   RHEUMATOLOGY INTERNATIONAL

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials

(2008) T Bongartz et al.   ANNALS OF THE RHEUMATIC DISEASES

Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen-induced arthritis

(2008) Percy F. Sumariwalla et al.   ARTHRITIS AND RHEUMATISM

Targeted therapies in breast cancer: Where are we now?

(2008) Serena Di Cosimo et al.   EUROPEAN JOURNAL OF CANCER

A pan-HER approach for cancer therapy: background, current status and future development

(2008) Zhongdong Huang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family

(2008) H. Michael Shepard et al.   JOURNAL OF CLINICAL INVESTIGATION

Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts

(2008) Jay Sarup et al.   MOLECULAR CANCER THERAPEUTICS

Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis

(2008) Pei Jin et al.   ARTHRITIS RESEARCH & THERAPY